Josefsson prostate cancer group

Research group The Josefsson lab is a multi-disciplinary bench-to-bedside research team in the Wallenberg Centre for Molecular Medicine, WCMM.

We aim to improve diagnostics, prognostics and treatment of prostate cancer using cutting edge techniques from whole body imaging down to molecular analysis of single cells. Within the group our experience includes clinical care, clinical trials, molecular biology, cell culture and much more.

Our expertise and position in Wallenberg Centre for Molecular Medicine (WCMM) and Umeå’s Translation Research Centre (TRC) enables us to do rapid patient to protein and nucleic acid level analysis as well as longer term model systems. In addition, we have a large network of collaborations allowing us to look at and combine all aspects of prostate cancer research.

Group members

Andreas Josefsson

Andreas is Consultant Urologist who defended his PhD titled “Prognostic markers in prostate cancer: studies of a watchful waiting cohort with long follow up” in 2011. He has published largely on studies into prostate cancer biomarkers. He combines clinical work with research and was appointed as an Assistant Professor at the WCMM in 2019.

Stina Rudolfsson

Stina is an expert in the molecular biology of prostate cancer specialising in cellular modelling with a focus on biomarkers. She defended her PhD at Umeå University “Vascular endothelial growth factor and prostate cancer” in 2000? Stina’s projects focus on advanced techniques to isolate and molecularly classify prostate cancer cells (for example isolation of Circulating Tumour Cells using acoustopheresis) and subsequent cellular and multicellular modelling of prostate cancer.

Sonja Edström

Sonja is a medical student with us on the Aspiring Researcher program. She has previously studied Biomedicine. She will be working on apoptosis influence on neighbouring cells in prostate cancer cell culture models.

Eva Freyhult

Eva is statistician and works within NBIS - National Bioinformatics Infrastructure Sweden. She works part time in the group and develop statistical methods for analysis of both clinicall trials and -omics data.